Information Provided By:
Fly News Breaks for February 29, 2016
HZNP
Feb 29, 2016 | 12:47 EDT
UBS said Horizon Pharma weakness related to a government subpoena is a buying opportunity. The firm's analyst said any investigation will take years to play out and fundamentals at the company continue to improve.
News For HZNP From the Last 2 Days
There are no results for your query HZNP